AI assistant
Sending…
DEXCOM INC — Director's Dealing 2015
May 28, 2015
30198_dirs_2015-05-28_815cadfe-5fc2-4b5a-88f1-badbe1f37731.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2015-05-27
Reporting Person: DOUBLEDAY RICHARD (EVP, Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-05-27 | Common Stock | S | 3258.0 | $70.728 | Disposed | 150568 | Direct |
Footnotes
F1: Included in this number are 107,500 unvested restricted stock units, 47,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018, 33,333 of which were granted on March 8, 2014 and shall vest through March 8, 2017, 10,000 of which were granted on May 31, 2013 and shall vest through May 31, 2016, and 16,667 of which were granted on March 11, 2013 and shall vest through March 11, 2016.
More from DEXCOM INC
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 15
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 17